FindTrial
Sign In

Analysis of clinical characteristics of severe novel coronavirus pneumonia (COVID-19)

Optimization of treatment and diagnosis plan for critically ill patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029805
Enrollment
Unknown
Registered
2020-02-14
Start date
2020-02-12
Completion date
Unknown
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

case series:N/A

Sponsors

Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with 2019-nCoV pneumonia; (2) Patients admitted to the ICU during the study period.

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

MeasureTime frame
28-day mortality and 90-day mortality.;—

Secondary

MeasureTime frame
Use of mechanical ventilation;Mechanical ventilation time;ICU hospital stay;Total hospital stay;—

Countries

China

Contacts

Public ContactWu Wenjuan

Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital)

88071718@qq.com+86 13397192695

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026